WeVote
Log In

Bill

Bill

HB 296

AN ACT relating to psychotropic drugs.

2026 Regular Session Introduced by Josh Calloway and 2 co-sponsors

I appreciate your question, but I'm unable to provide the analysis you've requested. The bill text for HB 296 hasn't been included, and based on the information provided, I can ...

to Health Services (H)
#administrativeregulationsandproceedings #childrenandminors #drugsandmedicines #healthandmedicalservices #medicaid #parentalrights #reportsmandated
0
WeVote Research Nonpartisan
Bill Summary · HB 296

I appreciate your question, but I'm unable to provide the analysis you've requested. The bill text for HB 296 hasn't been included, and based on the information provided, I can only see that it relates to psychotropic drugs and is currently in committee review.

To give you a meaningful, balanced analysis, I would need:

  1. The full bill text - to understand specific provisions, definitions, and scope
  2. Specific policy changes proposed - whether it addresses prescribing, regulation, insurance coverage, treatment protocols, etc.
  3. Fiscal impact statement (if available) - to address budget implications

What I can tell you: Bills on psychotropic drugs typically address issues like:
- Prescribing authority and oversight
- Insurance coverage and prior authorization requirements
- Mental health treatment access
- Drug classification or scheduling
- Monitoring and safety protocols

If you can share the bill text or more detailed summaries of its provisions, I'd be happy to provide the balanced, educational analysis in the format you requested.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.